難溶性医薬品結晶の超微細化方法の開発に関する研究(第3報)オキソリン酸結晶の超微細化の成因の推論

DOI Web Site Web Site

書誌事項

タイトル別名
  • Studies on Development of the Ultra-fine Size Reduction Method of Slightly Soluble Medicinal Crystals. III. The Inference of Origin for Ultra-fine Size Reduction of Oxolinic Acid Crystal
  • 難溶性医薬品結晶の超微細化方法の開発に関する研究-3-オキソリン酸結晶の超微細化の成因の推論
  • ナンヨウセイ イヤクヒン ケッショウ ノ チョウ ビサイカ ホウホウ ノ カイ

この論文をさがす

抄録

It was found in the previous papers that oxolinic acid (OA) crystals were reduced to ultra-fine size by the new method of present authors. Therefore, several investigations were carried out to infer the origin for ultra-fine size reduction in this paper. It was inferable from the results that surfactants or polymers which coexisted in the crystal formation-growth process adsorbed on the surface of microparticles, and the size reduction effect had been displayed due to suppressing the aggregation for their dispersing action.

収録刊行物

  • 薬学雑誌

    薬学雑誌 103 (11), 1215-1218, 1983

    公益社団法人 日本薬学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ